Printer Friendly

COMPANY INFORMATION
Wex Pharmaceuticals Inc. 1601-700 Pender St W Vancouver, BC V6C 1G8 Tel: (604) 683-8880 Toll-free: (800) 722-7549 Fax: (604) 683-8868 Contact Name Kwong Choo Industry Pharmaceuticals		Key Executives Bin Huang, CEO Kwong Choo, CFO Develops drugs for the treatment of moderate to severe acute and chronic pain, symptom pain relief associated with opioid addiction withdrawal and local anaesthetics.
FP ADVISOR COVERAGE Wex Pharmaceuticals Inc. • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Predecessor & Defunct • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/WXI $0.14 $0.35 $0.12 n.a. n.a. n.a. 1.61 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 12,136 n.a. $-0.14 Sept. 30/09 -51.1% -25.72% -45.66% $23,893
ANNUAL FINANCIALS Periods ended: 12m Mar. 31/09 12m Mar. 31/08 12m Mar. 31/07 $000s $000s $000s Operating revenue nil 1,002 545 Net income (8,048) (2,799) (4,760) Total assets 11,332 7,519 5,333 $ $ $ Earnings per share* (0.13) (0.05) (0.13) % % % Return on equity n.m. (166.71) (307.10)   * Restricted vtg.
TRAILING 12-MONTH VALUES Periods ended: Sept. 30/09 Sept. 30/08 $000s $000s Operating revenue nil 210 Net income (8,584) (5,040) $ $ Earnings per share (0.13) (0.08)

COMPANY NEWS

Results for 'Wex Pharmaceuticals Inc.' from past 30 days: No hits. (Links are to articles.)